Items where Author is "Laban, Simon"

Article

Hecht, Markus and Frey, Benjamin and Gaipl, Udo S. and Xie, Tianyu and Eckstein, Markus and Donaubauer, Anna-Jasmina and Klautke, Gunther and Illmer, Thomas and Fleischmann, Maximilian and Laban, Simon and Hautmann, Matthias G. and Tamaskovics, Balint and Brunner, Thomas B. and Becker, Ina and Zhou, Jian-Guo and Hartmann, Arndt and Fietkau, Rainer and Iro, Heinrich and Doellinger, Michael and Gostian, Antoniu-Oreste and Kist, Andreas M. (2024) Machine Learning-assisted immunophenotyping of peripheral blood identifies innate immune cells as best predictor of response to induction chemo-immunotherapy in head and neck squamous cell carcinoma - knowledge obtained from the CheckRad-CD8 trial. NEOPLASIA, 49: 100953. ISSN 1476-5586,

Hecht, Markus and Eckstein, Markus and Rutzner, Sandra and von Der Grun, Jens and Illmer, Thomas and Klautke, Gunther and Laban, Simon and Hautmann, Matthias G. and Brunner, Thomas B. and Tamaskovics, Balint and Hinke, Axel and Zhou, Jian-Guo and Frey, Benjamin and Donaubauer, Anna-Jasmina and Becker, Ina and Semrau, Sabine and Hartmann, Arndt and Balermpas, Panagiotis and Budach, Wilfried and Gaipl, Udo S. and Iro, Heinrich and Gostian, Antoniu-Oreste and Fietkau, Rainer (2022) Induction chemoimmunotherapy followed by CD8+immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancer. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 10 (1): e003747. ISSN , 2051-1426

Semrau, Sabine and Gostian, Antoniu-Oreste and Traxdorf, Maximilian and Eckstein, Markus and Rutzner, Sandra and von der Grun, Jens and Illmer, Thomas and Hautmann, Matthias and Klautke, Gunther and Laban, Simon and Brunner, Thomas and Tamaskovics, Balint and Frey, Benjamin and Zhou, Jian-Guo and Geppert, Carol-Immanuel and Hartmann, Arndt and Balermpas, Panagiotis and Budach, Wilfried and Gaipl, Udo and Iro, Heinrich and Fietkau, Rainer and Hecht, Markus (2021) Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer. CANCERS, 13 (8): 1959. ISSN , 2072-6694

Hecht, Markus and Gostian, Antoniu Oreste and Eckstein, Markus and Rutzner, Sandra and von der Gruen, Jens and Illmer, Thomas and Hautmann, Matthias G. and Klautke, Gunther and Laban, Simon and Brunner, Thomas and Hinke, Axel and Becker, Ina and Frey, Benjamin and Semrau, Sabine and Geppert, Carol and Hartmann, Arndt and Balermpas, Panagiotis and Budach, Wilfried and Gaipl, Udo S. and Iro, Heinrich and Fietkau, Rainer (2020) Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 8 (2): e001378. ISSN 2051-1426

Krupar, Rosemarie and Hautmann, Matthias G. and Pathak, Ravi R. and Varier, Indu and McLaren, Cassandra and Gaag, Doris and Hellerbrand, Claus and Evert, Matthias and Laban, Simon and Idel, Christian and Sandulache, Vlad and Perner, Sven and Bosserhoff, Anja K. and Sikora, Andrew G. (2018) Immunometabolic Determinants of Chemoradiotherapy Response and Survival in Head and Neck Squamous Cell Carcinoma. AMERICAN JOURNAL OF PATHOLOGY, 188 (1). pp. 72-83. ISSN 0002-9440, 1525-2191

Conference or Workshop Item

Hecht, Markus and Eckstein, Markus and Kallies, Annett and Klautke, Gunther and Illmer, Thomas and Von der Gruen, Jens and Laban, Simon and Hautmann, Matthias G. and Tamaskovics, Balint and Brunner, Thomas and Hinke, Axel and Frey, Benjamin and Semrau, Sabine and Hartmann, Arndt and Balermpas, Panagiotis and Budach, Wilfried and Gaipl, Udo S. and Iro, Heinrich and Gostian, Antoniu-Oreste and Fietkau, Rainer (2022) Pathologic response after induction chemo-immunotherapy with single or double immune checkpoint inhibition in locally advanced head and neck squamous cell carcinoma (HNSCC): Expansion cohorts of the CheckRad-CD8 trial. In: Annual Meeting of the American Society of Clinical Oncology (ASCO), June 03-07, 2022, Elec Network.

Tometten, Mareike and Rolles, Benjamin and Klein, Maurice and Ooms, Mark and Winnand, Philipp and Simons, Eva and Bourgeois, Marcel and Spanier, Gerrit and Laban, Simon and Weber, Manuel and Goetz, Carolin and Birkenfeld, Falk and Kricheldorf, Kim and Isfort, Susanne and Kirschner, Martin and Hackenberg, Stephan and Hoelzle, Frank and Beier, Fabian and Bruemmendorf, Tim H. (2022) Telomere length screening in young patients with head and neck squamous cell carcinoma is suitable to detect underlying inherited telomere biology disorders. In: 35. Deutscher Krebskongress, Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung, 13.–16. November 2022, Berlin.

Hecht, Markus and Eckstein, Markus and Kallies, Annett and Von der Grün, Jens and Illmer, Thomas and Klautke, Gunther and Laban, Simon and Hautmann, Matthias and Brunner, Thomas and Tamaskovics, Balint and Hinke, Axel and Zhou, Jian-Guo and Frey, Benjamin and Donaubauer, Anna-Jasmina and Becker, Ina and Semrau, Sabine and Hartmann, Arndt and Balermpas, Panagiotis and Budach, Wilfried and Gaipl, Udo and Iro, Heinrich and Gostian, Antoniu-Oreste and Fietkau, Rainer (2022) Updated analysis of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma with induction chemoimmunotherapy followed by radioimmunotherapy. In: 35. Deutscher Krebskongress, Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung, 13.–16. November 2022, Berlin.

Hecht, Markus and Eckstein, Markus and Rutzner, Sandra and von der Gruen, Jens and Illmer, Thomas and Klautke, Gunther and Laban, Simon and Hautmann, Matthias G. and Brunner, Thomas and Tamaskovics, Balint and Hinke, Axel and Frey, Benjamin and Semrau, Sabine and Hartmann, Arndt and Balermpas, Panagiotis and Budach, Wilfried and Gaipl, Udo S. and Iro, Heinrich and Gostian, Antoniu-Oreste and Fietkau, Rainer (2021) Primary results of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma (HNSCC) with double checkpoint blockade and radiotherapy dependent on intratumoral CD8+T-cell infiltration. In: 2021 ASCO Annual Meeting, 4. Juni - 8. Juni 2021, Online.

Hecht, Markus and Gostian, Antoniu-Oreste and Eckstein, Markus and Rutzner, Sandra and von der Gruen, Jens and Illmer, Thomas and Hautmann, Matthias G. and Brunner, Thomas and Laban, Simon and Klautke, Gunther and Tamaskovics, Balint and Hinke, Axel and Frey, Benjamin and Semrau, Sabine and Hartmann, Arndt and Roedel, Claus and Budach, Wilfried and Gaipl, Udo S. and Iro, Heinrich and Fietkau, Rainer (2020) A multicenter phase II trial of the combination cisplatin/ docetaxel/durvalumab/tremelimumab as single-cycle induction treatment in locally advanced HNSCC (CheckRad-CD8 trial). In: 2020 ASCO Annual Meeting I - Virtual Scientific Program.